Repligen Corp.
(NASDAQ : RGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.09%145.210.7%$864.96m
PFEPfizer Inc. 2.06%38.200.9%$794.52m
MRKMerck & Co., Inc. 0.85%79.880.7%$633.76m
ABBVAbbVie, Inc. 0.13%84.421.9%$605.70m
BMYBristol-Myers Squibb Co. -1.05%60.121.0%$597.45m
LLYEli Lilly & Co. 0.48%142.331.1%$480.95m
AZNAstraZeneca Plc 0.08%52.001.2%$210.07m
GSKGlaxoSmithKline Plc 0.60%35.300.2%$147.41m
NVSNovartis AG 0.07%84.470.2%$138.31m
NVONovo Nordisk A/S -0.20%70.740.1%$71.09m
RGENRepligen Corp. -0.15%176.257.1%$66.58m
RPRXRoyalty Pharma Plc -0.51%39.010.2%$65.42m
SNYSanofi 0.82%49.330.2%$48.25m
AMAGAMAG Pharmaceuticals, Inc. 0.07%13.6722.1%$45.61m
OPKOPKO Health, Inc. 0.70%4.3011.2%$41.80m

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.